Same-Day Coordination of Mohs Surgery, Lymphoscintigraphy, and Sentinel Lymph Node Biopsy for Merkel Cell Carcinoma: A Single-Center Feasibility Report
Authors:
- Victoria H. RueschVRVictoria H. Ruesch
- Justin ThrushJTJustin Thrush
- James F. BenaJBJames F. Bena
- Claudia RicottiCRClaudia Ricotti
- Melissa PiliangMPMelissa Piliang
- Melissa McEnery-StonelakeMMMelissa McEnery-Stonelake
- Basia Marie Michalski-McNeelyBMBasia Marie Michalski-McNeely
- Jon MeineJMJon Meine
- Jennifer LucasJLJennifer Lucas
- Christine Poblete-LopezCPChristine Poblete-Lopez
- Shlomo KoyfmanSKShlomo Koyfman
- Brian GastmanBGBrian Gastman
Open Access
Abstract
Background/Objectives: Merkel cell carcinoma (MCC) is an aggressive neuroendocrine tumor, most commonly occurring on the head and neck. Incidence of MCC is rising with the aging population. Five-year overall survival (OS) for localized MCC is 50.6%; 5-year OS for patients with distant metastases is 13.5%. The purpose of this study is to determine if coordination of care for the treatment of MCC is logistically feasible, and provide a description of the patient population observed at this institution. Methods: All patients with MCC diagnosis from January 2012–June 2024 were identified at our tertiary care center. All patients with MCC were added to our non-melanoma skin cancer registry. Outcomes were compared between those treated with our “Merkel cell carcinoma in a day” (MIAD) protocol and those receiving the standard treatment protocol. Results: No significant differences were detected in the recurrence rate, transit metastasis, distant metastasis, and disease-specific death. Nodal metastasis was higher in the MIAD group (HR 4.94, 95% CI 1.08–22.6, p = 0.039, six events total). Both groups had similar times to treatment and treatment within 30 days of diagnosis. Conclusions: MCC is a rare and aggressive tumor, often exhibiting subclinical tumor spread. Mohs micrographic surgery ensures 100% peripheral and deep margin assessment, with potential for tissue sparing. With thoughtful coordination, lymphoscintigraphy can be completed on the same day as Mohs surgery followed by sentinel lymph node biopsy (SLNB) and reconstructive surgery.Keywords
This publication has 28 references indexed in Scilit:
- MMS hotspots: a cross-sectional comparison of U.S. counties with and without Mohs micrographic surgeryArchives of Dermatological Research, 2023
- Overall Survival After Mohs Surgery for Early-Stage Merkel Cell CarcinomaJAMA Dermatology, 2023
- The impact of facility characteristics on Merkel cell carcinoma outcomes: A retrospective cohort studyJournal of the American Academy of Dermatology, 2023
- Recurrence and Mortality Risk of Merkel Cell Carcinoma by Cancer Stage and Time From DiagnosisJAMA Dermatology, 2022
- A retrospective cohort study of comprehensive peripheral and deep margin assessment in Merkel cell carcinoma: Standard margins may be unreliableJournal of the American Academy of Dermatology, 2021
- Travel burden associated with rare cancers: The example of Merkel cell carcinomaCancer Medicine, 2019
- Merkel cell carcinoma: An update and reviewJournal of the American Academy of Dermatology, 2018
- Merkel cell carcinoma: Current US incidence and projected increases based on changing demographicsJournal of the American Academy of Dermatology, 2018
- Merkel cell carcinoma: Epidemiology, prognosis, therapy and unmet medical needsEuropean Journal of Cancer, 2017
- An intact retinoblastoma protein‐binding site in Merkel cell polyomavirus large T antigen is required for promoting growth of Merkel cell carcinoma cellsInternational Journal of Cancer, 2011